Trials / Withdrawn
WithdrawnNCT05654064
Comparing Fetoscopic Surgery Protocols
Comparison of Remifentanil-dexmedetomidine and Dexmedetomidine-fentanyl Sedation Protocols for Pregnant Patients Undergoing Minimally Invasive Fetoscopic Procedures
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Children's Hospital Medical Center, Cincinnati · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Determine surgeon and patient satisfaction with remifentanil-dexmedetomidine (REMI) and dexmedetomidine-fentanyl (DEX) sedation protocols in pregnant patients undergoing minimally invasive fetoscopic procedures
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remifentanil-dexmedetomidine | Compare adequacy of remifentanil-dexmedetomidine sedation protocols in pregnant patients undergoing minimally invasive fetoscopic procedures. |
| DRUG | Dexmedetomidine-fentanyl | Compare adequacy of dexmedetomidine-fentanyl sedation protocols in pregnant patients undergoing minimally invasive fetoscopic procedures. |
Timeline
- Start date
- 2022-04-01
- Primary completion
- 2024-04-01
- Completion
- 2024-04-01
- First posted
- 2022-12-16
- Last updated
- 2022-12-16
Source: ClinicalTrials.gov record NCT05654064. Inclusion in this directory is not an endorsement.